ArticleBreast cancer research and treatment2018
Use of dual mTOR inhibitor MLN0128 against everolimus-resistant breast cancer.
Karineh Petrossian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it